The Primary Care Companion For CNS Disorders
June 25, 2026
Franklin King, Juliana Zambrano, Erin Mauney et al.
The Psychiatric Consultation Service at Massachusetts General Hospital sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. During their twice-weekly rounds, Dr Stern and other members of the Consultation Service discuss diagnosis and management of hospitalized patients with complex medical or surgical problems who also demonstrate psychiatric symptoms or...
The Primary Care Companion For CNS Disorders
June 23, 2026
Franklin King, Brian S. Barnett, S Trevor Taylor et al.
The Psychiatric Consultation Service at Massachusetts General Hospital sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. During their twice-weekly rounds, Dr Stern and other members of the Consultation Service discuss diagnosis and management of hospitalized patients with complex medical or surgical problems who also demonstrate psychiatric symptoms or...
Journal of immigrant and minority health
June 9, 2025
Juliana Zambrano, Fernando Espí Forcén, Jose Hidalgo et al.
Despite increasing interest in psychedelic-assisted therapies (PAT), there remains a critical gap in extending these treatments to marginalized and vulnerable populations, including Latinx immigrants. This underrepresentation in both research and clinical practice exacerbates disparities in mental health care access for racial and ethnic minorities, who already face systemic barriers. The...
Imafronte
April 11, 2025
Fernando Espí Forcén
Alejandro Jodorowsky’s cult classic The Holy Mountain was released in 1973 and has since enjoyed a growing cult status, further fueled by the recent psychedelic renaissance movement. In a humorous tone, The Holy Mountain incorporates the ideas and values of its time, such as the countercultural movement that rejected the establishment and traditional lifestyles while embracing alternative...
Journal of Psychoactive Drugs
January 7, 2025
Fernando Espí Forcén
As psilocybin awaits approval by the Food and Drug Administration (FDA), scholars debate whether psychedelic-assisted psychotherapy should be required when prescribing this medicine. Here, we report the case of a patient who underwent a psilocybin experience without psychedelic-assisted psychotherapy, resulting in inpatient psychiatric admission. This case underscores the importance of taking...
Journal of psychopharmacology (Oxford, England)
2025
Kabir Nigam, Franklin King, Fernando Espí Forcén
4 citations
Ketamine has recently been shown to be non-inferior to electroconvulsive therapy (ECT), one of psychiatry's most effective treatments for depression. Given the novelty of ketamine as well as its interventional nature, ketamine is currently viewed as an alternative to ECT and as such, considered a third-line agent for treatment-refractory depression. However, available data suggest that ketamine...
The British journal of psychiatry : the journal of mental science
October 25, 2024
Kabir Nigam, Franklin King, Fernando Espí Forcén
2 citations
Evidence indicates that ketamine is highly effective, has a lower side effect profile and is better tolerated compared to many augmentation strategies for refractory depression. This, combined with data on psychiatric treatment outcome mediators, suggests that earlier intervention with ketamine could improve outcomes for patients suffering from refractory depression.
Psychiatric Annals
December 1, 2023
Fernando Espí Forcén
3 citations
Hispanic and Latinx people practice spirituality in a wide array of forms. Whereas Catholicism has been the dominant religion for centuries, a re-birth of Native American and African spirituality has taken place over the last few decades. In parallel, the influence of the United States in the Latin world is reflected in the rapidly growing popularity of Evangelical Christianity. In order to...
The Journal of Clinical Psychiatry
April 5, 2023
Albert Yeung, Guy Sapirstein, Laura D Crain et al.
Although consensus in the field is lacking, the most common definition for treatment-resistant depression (TRD) requires a minimum of 2 prior treatment failures with confirmed adequate dose and duration. This article presents a clinical example of TRD in a patient with a long history of depression and inadequate response to treatment. The prominent feature is the patient's persistent...
Palliative and Supportive Care
April 1, 2023
Fernando Espí Forcén, Laura Marengo, Maya Behn
AbstractThere is a current debate in society as to whether depression can be a terminal illness. Meaning-centered psychotherapy (MCP) and psychedelic medicines have both been shown to treat existential distress in palliative care settings. We are reporting the case of a patient for whom MCP combined with ketamine was an effective treatment for his recurrent and severe depressive disorder with...
Psychiatric Annals
September 1, 2022
Fernando Espí Forcén, Maren Nyer
To date, ketamine is the only prescribable psychedelic medicine in the United States. Ketamine is also one of the most promising drugs for the treatment of depression. In the current paradigm of care, most ketamine clinics in the United States treat patients with mood disorders with ketamine and its derivatives alone without psychotherapy. The purpose of this article is to review the most...